文献速递肝病

磁共振成像肝脏质子密度脂肪分数在儿童非酒精性脂肪性肝病中的诊断准确性

Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease.
PubMed 文献 · Hepatology · 2018-01-26

研究评估磁共振成像质子密度脂肪分数(MRI-PDFF)在儿童非酒精性脂肪性肝病(NAFLD)中分层肝脂肪变分级及治疗前后变化的能力,以中心化评分的组织学为参考。169名入组儿童中110名有基线MRI和肝活检,83名有治疗终点(52周)数据。PDFF对脂肪变分级及变化具有高诊断准确性。

要点

  • 基线PDFF均值随组织学脂肪变分级升高:1级10.9±4.1%,2级18.4±6.2%,3级25.7±9.7%。
  • PDFF区分1级 vs 2-3级和1-2级 vs 3级的AUROC分别为0.87和0.79。
  • 治疗终点PDFF变化可区分脂肪变改善(AUROC 0.76)和加重(AUROC 0.83)。

核心结论

  • MRI估算的PDFF在儿童NAFLD中对于分类和预测组织学脂肪变分级及其变化具有高诊断准确性。

研究设计与样本

  • 研究为CyNCh试验的子研究,使用中心化评分的组织学作为参考标准,评估MRI-PDFF在儿童NAFLD中的性能。
  • 参与者使用来自三家制造商的扫描仪进行多回波1.5T或3T MRI检查。
  • 169名入组儿童中,110名(65%)有基线MRI和肝活检,83名(49%)有治疗终点(52周)的MRI和肝活检。

主要发现

  • 基线时,肝活检显示组织学脂肪变1级、2级、3级分别占17%(19/110)、28%(31/110)、55%(60/110),对应PDFF均值±标准差分别为10.9±4.1%、18.4±6.2%、25.7±9.7%。
  • PDFF分类1级 vs 2-3级和1-2级 vs 3级脂肪变的AUROC分别为0.87(95%CI 0.80, 0.94)和0.79(95%CI 0.70, 0.87)。
  • 90%特异性下,PDFF区分2-3级脂肪变的截断值为17.5%,区分3级脂肪变的截断值为23.3%。
  • 治疗终点时,肝活检显示脂肪变分级改善、不变、加重分别占47%(39/83)、41%(34/83)、12%(10/83),对应PDFF变化均值±标准差分别为-7.8±6.3%、-1.2±7.8%、4.9±5.0%。
  • PDFF变化分类脂肪变分级改善和加重的AUROC(95%CI)分别为0.76(0.66, 0.87)和0.83(0.73, 0.92);90%特异性下,改善和加重的截断值分别为-11.0%和+5.5%。

关键数值与推荐

  • PDFF分类1级 vs 2-3级脂肪变的AUROC为0.87(95%CI 0.80, 0.94)。
  • PDFF分类1-2级 vs 3级脂肪变的AUROC为0.79(95%CI 0.70, 0.87)。
  • 90%特异性下,PDFF区分2-3级脂肪变的截断值为17.5%,区分3级脂肪变的截断值为23.3%。
  • PDFF变化分类脂肪变改善的AUROC为0.76(95%CI 0.66, 0.87),加重的AUROC为0.83(95%CI 0.73, 0.92)。
  • 90%特异性下,PDFF变化区分脂肪变改善的截断值为-11.0%,区分加重的截断值为+5.5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We assessed the performance of magnetic resonance imaging (MRI) proton density fat fraction (PDFF) in children to stratify hepatic steatosis grade before and after treatment in the Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease in Children (CyNCh) trial, using centrally scored histology as reference. Participants had multiecho 1.5 Tesla (T) or 3T MRI on scanners from three manufacturers. Of 169 enrolled children, 110 (65%) and 83 (49%) had MRI and liver biopsy at baseline and at end of treatment (EOT; 52 weeks), respectively. At baseline, 17% (19 of 110), 28% (31 of 110), and 55% (60 of 110) of liver biopsies showed grades 1, 2, and 3 histological steatosis; corresponding PDFF (mean ± SD) values were 10.9 ± 4.1%, 18.4 ± 6.2%, and 25.7 ± 9.7%, respectively. PDFF classified grade 1 versus 2-3 and 1-2 versus 3 steatosis with areas under receiving operator characteristic curves (AUROCs) of 0.87 (95% confidence interval [CI], 0.80, 0.94) and 0.79 (0.70, 0.87), respectively. PDFF cutoffs at 90% specificity were 17.5% for grades 2-3 steatosis and 23.3% for grade 3 steatosis. At EOT, 47% (39 of 83), 41% (34 of 83), and 12% (10 of 83) of biopsies showed improved, unchanged, and worsened steatosis grade, respectively, with corresponding PDFF (mean ± SD) changes of -7.8 ± 6.3%, -1.2 ± 7.8%, and 4.9 ± 5.0%, respectively. PDFF change classified steatosis grade improvement and worsening with AUROCs (95% CIs) of 0.76 (0.66, 0.87) and 0.83 (0.73, 0.92), respectively. PDFF change cut-off values at 90% specificity were -11.0% and +5.5% for improvement and worsening. CONCLUSION: MRI-estimated PDFF has high diagnostic accuracy to both classify and predict histological steatosis grade and change in histological steatosis grade in children with NAFLD. (Hepatology 2018;67:858-872).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Middleton MS, Van Natta ML, Heba ER, et al. Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology. 2018. PMID: 29028128. doi:10.1002/hep.29596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。